Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD

3.8  -0.08 (-2.06%)

After market: 3.83 +0.03 (+0.79%)

Fundamental Rating

4

OSUR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for OSUR as it has an excellent financial health rating, but there are worries on the profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OSUR was profitable.
OSUR had a positive operating cash flow in the past year.
In multiple years OSUR reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

1.2 Ratios

OSUR has a Return On Assets of 2.45%. This is in the better half of the industry: OSUR outperforms 75.00% of its industry peers.
With a decent Return On Equity value of 2.67%, OSUR is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA 2.45%
ROE 2.67%
ROIC N/A
ROA(3y)0.7%
ROA(5y)0.72%
ROE(3y)0.5%
ROE(5y)0.64%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

With a decent Profit Margin value of 5.07%, OSUR is doing good in the industry, outperforming 76.06% of the companies in the same industry.
OSUR's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of OSUR has declined.
OSUR has a Gross Margin of 42.26%. This is in the lower half of the industry: OSUR underperforms 67.02% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.07%
GM 42.26%
OM growth 3YN/A
OM growth 5Y-6.47%
PM growth 3YN/A
PM growth 5Y3.34%
GM growth 3Y-10.5%
GM growth 5Y-7.41%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSUR has more shares outstanding
Compared to 5 years ago, OSUR has more shares outstanding
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

OSUR has an Altman-Z score of 5.38. This indicates that OSUR is financially healthy and has little risk of bankruptcy at the moment.
OSUR has a Altman-Z score of 5.38. This is in the better half of the industry: OSUR outperforms 79.79% of its industry peers.
The Debt to FCF ratio of OSUR is 0.00, which is an excellent value as it means it would take OSUR, only 0.00 years of fcf income to pay off all of its debts.
OSUR's Debt to FCF ratio of 0.00 is amongst the best of the industry. OSUR outperforms 93.62% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
The Debt to Equity ratio of OSUR (0.00) is better than 69.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.38
ROIC/WACCN/A
WACC9.04%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 12.60 indicates that OSUR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 12.60, OSUR belongs to the top of the industry, outperforming 96.28% of the companies in the same industry.
OSUR has a Quick Ratio of 11.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR has a Quick ratio of 11.20. This is amongst the best in the industry. OSUR outperforms 95.21% of its industry peers.
Industry RankSector Rank
Current Ratio 12.6
Quick Ratio 11.2
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.71%.
Measured over the past years, OSUR shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.25% on average per year.
OSUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.46%.
The Revenue has been growing by 17.41% on average over the past years. This is quite good.
EPS 1Y (TTM)-81.71%
EPS 3YN/A
EPS 5Y20.25%
EPS Q2Q%-140%
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y33.17%
Revenue growth 5Y17.41%
Sales Q2Q%-55.25%

3.2 Future

The Earnings Per Share is expected to decrease by -29.31% on average over the next years. This is quite bad
Based on estimates for the next years, OSUR will show a very negative growth in Revenue. The Revenue will decrease by -27.07% on average per year.
EPS Next Y-120.48%
EPS Next 2Y-52.84%
EPS Next 3Y-29.31%
EPS Next 5YN/A
Revenue Next Year-53.91%
Revenue Next 2Y-39.87%
Revenue Next 3Y-27.07%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

OSUR is valuated quite expensively with a Price/Earnings ratio of 25.33.
OSUR's Price/Earnings ratio is a bit cheaper when compared to the industry. OSUR is cheaper than 79.79% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.62. OSUR is around the same levels.
The Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 25.33
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

98.94% of the companies in the same industry are more expensive than OSUR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, OSUR is valued cheaply inside the industry as 99.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.43
EV/EBITDA 2.96
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

OSUR's earnings are expected to decrease with -29.31% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.25
EPS Next 2Y-52.84%
EPS Next 3Y-29.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (2/21/2025, 8:00:02 PM)

After market: 3.83 +0.03 (+0.79%)

3.8

-0.08 (-2.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners91.87%
Inst Owner Change-94.84%
Ins Owners3.03%
Ins Owner Change0.63%
Market Cap283.44M
Analysts76.36
Price Target4.59 (20.79%)
Short Float %2.64%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.3%
Min EPS beat(2)23.28%
Max EPS beat(2)67.32%
EPS beat(4)3
Avg EPS beat(4)-112.89%
Min EPS beat(4)-753.59%
Max EPS beat(4)211.42%
EPS beat(8)7
Avg EPS beat(8)294.42%
EPS beat(12)8
Avg EPS beat(12)193.48%
EPS beat(16)9
Avg EPS beat(16)104.56%
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.29%
Max Revenue beat(2)2.18%
Revenue beat(4)4
Avg Revenue beat(4)1.18%
Min Revenue beat(4)0.29%
Max Revenue beat(4)2.18%
Revenue beat(8)8
Avg Revenue beat(8)12.11%
Revenue beat(12)12
Avg Revenue beat(12)12.04%
Revenue beat(16)15
Avg Revenue beat(16)10.24%
PT rev (1m)-10%
PT rev (3m)-28.95%
EPS NQ rev (1m)-6.26%
EPS NQ rev (3m)-6.26%
EPS NY rev (1m)0%
EPS NY rev (3m)3.63%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 25.33
Fwd PE N/A
P/S 1.26
P/FCF 4.43
P/OCF 4.13
P/B 0.67
P/tB 0.73
EV/EBITDA 2.96
EPS(TTM)0.15
EY3.95%
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)0.86
FCFY22.58%
OCF(TTM)0.92
OCFY24.22%
SpS3.01
BVpS5.71
TBVpS5.22
PEG (NY)N/A
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 2.45%
ROE 2.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.07%
GM 42.26%
FCFM 28.54%
ROA(3y)0.7%
ROA(5y)0.72%
ROE(3y)0.5%
ROE(5y)0.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.47%
PM growth 3YN/A
PM growth 5Y3.34%
GM growth 3Y-10.5%
GM growth 5Y-7.41%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0.07
Cap/Depr 38.97%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion 4028.64%
Profit Quality 563.07%
Current Ratio 12.6
Quick Ratio 11.2
Altman-Z 5.38
F-Score6
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)293.12%
Cap/Depr(5y)262.83%
Cap/Sales(3y)13.21%
Cap/Sales(5y)12.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.71%
EPS 3YN/A
EPS 5Y20.25%
EPS Q2Q%-140%
EPS Next Y-120.48%
EPS Next 2Y-52.84%
EPS Next 3Y-29.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y33.17%
Revenue growth 5Y17.41%
Sales Q2Q%-55.25%
Revenue Next Year-53.91%
Revenue Next 2Y-39.87%
Revenue Next 3Y-27.07%
Revenue Next 5YN/A
EBIT growth 1Y-117.13%
EBIT growth 3YN/A
EBIT growth 5Y9.82%
EBIT Next Year-68.88%
EBIT Next 3Y-41.78%
EBIT Next 5YN/A
FCF growth 1Y149.46%
FCF growth 3YN/A
FCF growth 5Y32.01%
OCF growth 1Y263.45%
OCF growth 3Y189.92%
OCF growth 5Y29.36%